In this study we have used a combined investigative model, analysing the transcriptional response in clinical tumour specimens from rectal adenocarcinomas and cancer cell lines, to identify APRIL, as a novel 5FU chemo-resistance biomarker. Here, TNFSF13 is linked to cancer.